7,786 reports of this reaction
4.1% of all CYCLOSPORINE reports
#3 most reported adverse reaction
EYE IRRITATION is the #3 most commonly reported adverse reaction for CYCLOSPORINE, manufactured by Allergan, Inc.. There are 7,786 FDA adverse event reports linking CYCLOSPORINE to EYE IRRITATION. This represents approximately 4.1% of all 190,279 adverse event reports for this drug.
Patients taking CYCLOSPORINE who experience eye irritation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE IRRITATION is moderately reported among CYCLOSPORINE users, representing a notable but not dominant share of adverse events.
In addition to eye irritation, the following adverse reactions have been reported for CYCLOSPORINE:
The following drugs have also been linked to eye irritation in FDA adverse event reports:
EYE IRRITATION has been reported as an adverse event in 7,786 FDA reports for CYCLOSPORINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE IRRITATION accounts for approximately 4.1% of all adverse event reports for CYCLOSPORINE, making it one of the most commonly reported side effect.
If you experience eye irritation while taking CYCLOSPORINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.